November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

Endovascular aneurysm repair (EVAR) has revolutionized treatment of abdominal aortic aneurysms. However, the applicability of EVAR continues to be challenged in patients with unfavorable anatomy ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

The preferred therapeutic options for infrarenal abdominal aortic aneurysms (AAAs) with short proximal landing zones are open surgical repair or endovascular treatment with custom-made fenestrated ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...

Small saphenous vein (SSV) reflux is an important and often overlooked cause of superficial venous insufficiency. It is present in about one-sixth of patients with superficial venous insufficiency, ...

Clinical performance of a medical device derives directly from its technical design and characteristics. Drug-coated balloons (DCBs) have to address several complex and contradictory demands. In an ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Assuming that there is a proper indication for IVC filter placement, the procedure is performed using sterile technique. In some instances, IVC filter placement has been performed using intravascular ...

The Vascular Disease Foundation (VDF) was formed in 1998 to improve public recognition of the prevalence and seriousness of vascular disease. It is a national not-for-profit, public 501(c)(3) ...